Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradat...
Q2 2026
Aug 10, 2026
Q1 2026
Apr 30, 2026
FY 2025
Feb 26, 2026
Q4 2025
Q3 2025
Nov 4, 2025